Quick Answer
IMMUCELL CORP /DE/ reported Gross Profit of $11.45 million for fiscal year 2025.
IMMUCELL CORP /DE/ Gross Profit — Annual History
| Fiscal Year | Gross Profit | YoY Change |
|---|---|---|
| 2025 | $11.45M | +44.1% |
| 2024 | $7.94M | +105.2% |
| 2023 | $3.87M | -49.4% |
| 2022 | $7.65M | -11.6% |
| 2021 | $8.66M | +26.1% |
| 2020 | $6.86M | +1.8% |
| 2019 | $6.74M | +29.8% |
| 2018 | $5.19M | -0.5% |
| 2017 | $5.22M | -3.7% |
| 2016 | $5.42M | -13.3% |
| 2015 | $6.25M | +40.5% |
| 2014 | $4.45M | +45.4% |
| 2013 | $3.06M | +0.2% |
| 2012 | $3.05M | +8.5% |
| 2011 | $2.81M | +22.2% |
| 2010 | $2.30M | -4.0% |
| 2009 | $2.40M | — |
Quarterly Gross Profit
| Quarter Ending | Gross Profit | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.36M | +49.2% | -16.1% |
| June 30, 2025 | $2.82M | +129.0% | -16.0% |
| March 31, 2025 | $3.35M | +46.1% | +111.8% |
| September 30, 2024 | $1.58M | +25.0% | +28.7% |
| June 30, 2024 | $1.23M | +17.9% | -46.4% |
| March 31, 2024 | $2.30M | +663.1% | +81.2% |
| September 30, 2023 | $1.27M | -31.4% | +21.4% |
| June 30, 2023 | $1.04M | -38.9% | +247.1% |
- IMMUCELL CORP /DE/ showed an increase of +44.1% in Gross Profit compared to the prior fiscal year.
- Over the 2009–2025 period, IMMUCELL CORP /DE/’s gross profit has grown by 377.3% (from $2.40 million to $11.45 million).
- The most recent figure is from IMMUCELL CORP /DE/’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 30, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: